Iron dextran and Neupogen drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Iron dextran (iron dextran) and Neupogen (filgrastim). Common drug interactions include hypophagia among females and blood pressure decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Iron dextran and Neupogen. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Iron dextran?

Iron dextran has active ingredients of iron dextran. It is often used in anemia. eHealthMe is studying from 1,487 Iron dextran users. Check the latest studies of Iron dextran.

What is Neupogen?

Neupogen has active ingredients of filgrastim. It is often used in agranulocytosis. eHealthMe is studying from 23,898 Neupogen users. Check the latest studies of Neupogen.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 04, 2026

22 people who take Iron dextran and Neupogen together, and have interactions are studied.

Iron dextran and Neupogen drug interactions.

What are the common drug interactions of Iron Dextran and Neupogen, by gender? *:

female:

Hypophagia (reduced food intake)
Coronary artery stenosis (narrowing of coronary artery)
Nausea (feeling of having an urge to vomit)
Pain
Abdominal pain
Abscess neck (neck abscesses)
Anaemia (lack of blood)
Anxiety
Candidiasis (candidiasis or thrush is a fungal infection)
Cardiac failure congestive

male:

Blood pressure decreased
Headache (pain in head)
Heart rate increased
Malaise (a feeling of general discomfort or uneasiness)
Pyrexia (fever)
Rigors (an episode of shaking or exaggerated shivering)
Sweating increased (excess sweating)
Vomiting

What are the common drug interactions of Iron Dextran and Neupogen, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Blood pressure decreased
Headache (pain in head)
Heart rate increased
Malaise (a feeling of general discomfort or uneasiness)
Pyrexia (fever)
Rigors (an episode of shaking or exaggerated shivering)
Sweating increased (excess sweating)
Vomiting

10-19:

n/a

20-29:

n/a

30-39:

Chest pain
Feeling hot
Hypotension (abnormally low blood pressure)
Loss of consciousness
Pulse pressure decreased
Red eye
Vision blurred
Visual disturbance

40-49:

n/a

50-59:

Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs)
Lymphadenopathy (disease or enlargement of lymph nodes)
Pleural effusion (water on the lungs)
Cardiomyopathy (weakening of the heart muscle)
Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
Hypotension (abnormally low blood pressure)
Asthma
Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
Cardiomegaly (increased size of heart than normal)

60+:

Abdominal pain upper
Balance disorder
Eating disorder
Fall
Fatigue (feeling of tiredness)
General physical health deterioration (weak health status)
Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
Hypoaesthesia (reduced sense of touch or sensation)
Malaise (a feeling of general discomfort or uneasiness)
Muscle spasms (muscle contraction)

What are the existing conditions these people have? *

Anaemia (lack of blood): 15 people, 68.18%
Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 13 people, 59.09%
Multiple Myeloma (cancer of the plasma cells): 13 people, 59.09%
Breast Cancer: 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Iron dextran and Neupogen?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously